• LinkedIn
• RSS

AMPA GluA1-flip targeted oligonucleotide therapy paper published in PLOS One Journal                 LifeSplice Pharma co-founders featured in local top entrepreneur list                 NIH Grant Awarded ($700 K) to Develop Drug to Treat Dravet Syndrome                 NIH P2-SBIR Grant Awarded ($3 Million) for Safety Studies of ALS Drug LSP-GR1